 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
2-23-2022
Insider Buy |
Sharon O'keefe
Director |
$20.63
CAGR »
|
$25,787.50
1,250 shares |
2-17-2022
Insider Buy |
Charles Deshazer
Director |
$20.65
CAGR »
|
$10,325.00
500 shares |
2-15-2022
Insider Buy |
Donna J. Hrinak
Director |
$24.09
CAGR »
|
$9,997.35
415 shares |
2-14-2022
Insider Buy |
Michael W. Malafronte
Director |
$23.58
CAGR »
|
$954,990.00
40,500 shares |
2-11-2022
Insider Buy |
Lyle Logan
Director |
$24.61
CAGR »
|
$39,999.94
1,625 shares |
2-11-2022
Insider Buy |
Georgette D. Kiser
Director |
$24.54
CAGR »
|
$2,453.50
100 shares |
2-10-2022
Insider Buy |
Michael W. Malafronte
Director |
$24.30
CAGR »
|
$294,030.00
12,100 shares |
2-10-2022
Insider Buy |
Lisa W. Wardell
Director |
$24.48
CAGR »
|
$98,409.60
4,020 shares |
2-10-2022
Insider Buy |
Kenneth J. Phelan
Director |
$24.47
CAGR »
|
$100,000.01
4,087 shares |
12-2-2021
Insider Buy |
Georgette D. Kiser
Director |
$29.06
CAGR »
|
$1,453.00
50 shares |
11-8-2021
Insider Buy |
Michael W. Malafronte
Director |
$32.99
CAGR »
|
$709,285.00
21,500 shares |
11-12-2021
Insider Buy |
Georgette D. Kiser
Director |
$32.99
CAGR »
|
$1,649.50
50 shares |
8-24-2021
Insider Buy |
Michael W. Malafronte
Director |
$35.99
CAGR »
|
$323,910.00
9,000 shares |
5-14-2021
Insider Buy |
Georgette D. Kiser
Director |
$37.83
CAGR »
|
$1,891.50
50 shares |
5-5-2021
Insider Buy |
Michael W. Malafronte
Director |
$34.04
CAGR »
|
$245,090.16
7,200 shares |
3-2-2021
Insider Buy |
Georgette D. Kiser
Director |
$38.35
CAGR »
|
$1,917.32
50 shares |
3-2-2021
Insider Buy |
Lyle Logan
Director |
$38.06
CAGR »
|
$39,999.96
1,051 shares |
2-16-2021
Insider Buy |
Donna J. Hrinak
Director |
$40.03
CAGR »
|
$20,016.00
500 shares |
2-16-2021
Insider Buy |
Kenneth J. Phelan
Director |
$41.00
CAGR »
|
$102,499.50
2,500 shares |
2-11-2021
Insider Buy |
Georgette D. Kiser
Director |
$41.00
CAGR »
|
$2,050.00
50 shares |
2-11-2021
Insider Buy |
James D. White
Director |
$41.04
CAGR »
|
$25,034.40
610 shares |
2-5-2021
Insider Buy |
Michael W. Malafronte
Director |
$39.25
CAGR »
|
$235,499.40
6,000 shares |
2-10-2021
Insider Buy |
Holland Katherine Alice Boden
Gr Pres Medical and Healthcare |
$40.94
CAGR »
|
$25,016.17
611 shares |
2-4-2021
Insider Buy |
William W. Burke
Director |
$40.06
CAGR »
|
$40,060.00
1,000 shares |
11-15-2019
Insider Buy |
Michael O. Randolfi
SVP, Chief Financial Officer |
$33.73
CAGR »
|
$1,079,379.20
32,000 shares |
11-11-2019
Insider Buy |
Holland Katherine Alice Boden
Gr Pres Medical and Healthcare |
$31.99
CAGR »
|
$63,986.80
2,000 shares |
Also See: Institutional Holders of ATGE
Also See: SEC filings
Below we present the annualized performance delivered by ATGE stock since 2-23-2022 (the date of the most recent
insider purchase). The performance of the investment from the time ATGE insider buying occurred is the ultimate
test of whether insiders were right about ATGE being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
02/24/2022 |
|
| End date: |
04/24/2024 |
|
| Start price/share: |
$20.12 |
|
| End price/share: |
$47.21 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
134.64% |
|
| Average Annual Total Return: |
48.37% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$23,463.31 |
|
| Years: |
2.16 |
|
ATGE Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent ATGE insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding ATGE
|
|
Free ATGE Email Alerts:
